See PACEOMICS policy briefs at: http://bit.ly/2al5MWA
Link to project description and methods, full downloadable bibliographic information and reading guide: http://paceomics.org/index.php/outputs/tools-and-resources/
Links to the following presentations HERE
Paulden, M., O’Mahony, J., and McCabe, C. The determinants of change in the cost-effectiveness threshold.
Akude, P., Mahjoub, R., Paulden, M., and McCabe, C. A framework for cost-effectiveness analysis of Personalized Medicine co-dependent technologies.
Paulden, M., O’Mahony, J., and McCabe, C. Decision rules for value-based reimbursement: Moving on from ‘net health benefit.’ (poster)
Analysis of major GE3LS issues involved in Precision Medicine is critical to the implementation of this approach in health care delivery. Cover story in Hospital News highlights the important role of the new Genome Canada Precision Medicine Policy Network. Includes comments from PACEOMICS PI, Christopher McCabe.
Network PIs Christopher McCabe (Paceomics PI, University of Alberta) and Francois Rousseau (Université Laval) talk about the goals & approach of the new Network. (podcast)
CHEO and Transgenomic reach agreement on Long QT patents that sets pathway for next generation of patient care
Professor Richard Gold, who leads the Intellectual Asset Management stream within PACEOMICS and is a James McGill Professor at McGill University’s Faculty of Law, advised the Children’s Hospital of Eastern Ontario (CHEO) on policy aspects of the case.
The genetic test you couldn’t get in Canada, until now (Global News)